ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,666.42
0.27%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Transition Therapeutics - Ordinary Shares (TTHI)

  7. Transition Therapeutics - Ordinary Shares (TTHI) Noticias

TTHI

Transition Therapeutics - Ordinary Shares (TTHI)

Transition Therapeutics - Ordinary Shares
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TTHI
FechaHoraFuenteTítuloSímboloCompañía
11/10/201612:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
13/09/201616:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
13/09/201616:14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
09/09/201613:04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
31/08/201607:56Edgar (US Regulatory)(25-NSE)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
31/08/201600:00Business WireOPKO Health Completes Acquisition of Transition TherapeuticsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/08/201607:52Business WireTransition Therapeutics Shareholders Approve Acquisition by OPKO HealthNASDAQ:TTHITransition Therapeutics - Ordinary Shares
25/08/201617:46PR Newswire (US)Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Ar...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
30/06/201601:00Business WireOPKO Health to Acquire Transition TherapeuticsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
03/06/201605:01PR Newswire (Canada)Transition Therapeutics Receives Notification From NASDAQNASDAQ:TTHITransition Therapeutics - Ordinary Shares
11/05/201615:01PR Newswire (Canada)Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
09/05/201615:01PR Newswire (Canada)Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:3...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
25/04/201615:01PR Newswire (Canada)Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701NASDAQ:TTHITransition Therapeutics - Ordinary Shares
18/04/201605:01PR Newswire (US)Transition Therapeutics Provides Update on Type 2 Diabetes Drug Candidate TT401NASDAQ:TTHITransition Therapeutics - Ordinary Shares
01/03/201615:30PR Newswire (Canada)Transition Therapeutics to Present at the 36th Annual Cowen Healthcare ConferenceNASDAQ:TTHITransition Therapeutics - Ordinary Shares
11/02/201616:26Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
09/02/201615:32PR Newswire (Canada)Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
05/02/201612:01PR Newswire (US)Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
01/02/201605:01PR Newswire (Canada)Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401NASDAQ:TTHITransition Therapeutics - Ordinary Shares
06/01/201605:01PR Newswire (Canada)Transition Therapeutics Announces Annual General Meeting Voting ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
19/11/201510:45PR Newswire (Canada)Transition Therapeutics to Host Investor Day November 23 in New YorkNASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/11/201515:01PR Newswire (US)Transition Therapeutics Announces First Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
02/11/201505:01PR Newswire (US)Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
29/10/201515:01PR Newswire (US)Transition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug CandidateNASDAQ:TTHITransition Therapeutics - Ordinary Shares
28/10/201505:01PR Newswire (US)Transition Therapeutics Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
15/10/201505:01PR Newswire (US)Transition Therapeutics Announces Results of Data Analysis from ELND005 Phase 2/3 Clinical Study in Agitation and Aggression ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
15/09/201515:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
15/09/201515:01PR Newswire (Canada)Transition Therapeutics Announces Fiscal 2015 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
14/09/201505:01PR Newswire (Canada)Transition Therapeutics to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. ESTNASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/08/201515:01PR Newswire (Canada)Transition Therapeutics to Present at the Canaccord Genuity 35th Annual Growth ConferenceNASDAQ:TTHITransition Therapeutics - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:TTHI

Su Consulta Reciente

COIN
XCEEUR
USOTC
LUGDF
Lundin Gold (QX)
USOTC
TRYMF
Treasury Metals (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados